Back
Corporate News
USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI
08-Feb-2025, 11:16
Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 ' 13 November 2024, as Voluntary Action Indicated (VAI).
Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 ' 13 November 2024, as Voluntary Action Indicated (VAI).
Powered by Capital Market - Live News